Naltrexon Vitaflo (Naltrexone Hydrochloride)

Naltrexone, the active ingredient in Naltrexon Vitaflo, is an opioid antagonist presented as an oral tablet for oral use. It is employed in the treatment of alcohol dependence and opioid dependence, helping to reduce cravings and prevent relapse in adults. GNH USA supplies Naltrexon Vitaflo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naltrexon Vitaflo is an opioid antagonist used in the management of disorders related to alcohol and opioid use. - Alcohol dependence: reduces cravings and helps maintain abstinence. - Opioid dependence: blocks opioid effects to prevent relapse and supports detoxification. - Substance use disorder: assists in managing dependence on both alcohol and opioids.

Naltrexon Vitaflo may be associated with a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headed sensation. - Fatigue: feeling unusually tired. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Hepatotoxicity: signs of liver injury such as jaundice. - Severe depression or suicidal thoughts: emergent mood changes requiring immediate attention. - Allergic reactions: rash, swelling, or anaphylaxis in rare cases.

Before initiating therapy, several safety considerations should be reviewed. - Liver function assessment: evaluate hepatic enzymes prior to use. - Depression monitoring: watch for worsening mood or suicidal ideation. - Acute opioid withdrawal: avoid initiating in patients currently dependent on opioids. - Renal impairment: adjust use in patients with reduced kidney function. - Concomitant medications: review for potential interactions. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Naltrexon Vitaflo can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Opioid analgesics: may precipitate acute withdrawal. - Benzodiazepines: increased risk of sedation and respiratory depression. - Disulfiram: combined hepatotoxic potential.

Moderate Interactions (Monitor Closely): - Antidepressants (especially SSRIs): monitor for serotonin syndrome. - Hepatotoxic agents (e.g., isoniazid): observe liver function regularly.